Meitav Dash Investments LTD Amgen Inc Transaction History

Meitav Dash Investments LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $43,711 - $51,687	204 New	204 $45,000
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $281,230 - $312,004	-1,204 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $124,269 - $144,816	-560 Reduced 31.75%	1,204 $301,000
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $381,694 - $454,529	1,764 New	1,764 $401,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.